The US Food and Drug Administration (FDA) has announced a voluntary recall of multiple drug products containing valsartan as the active ingredient following the detection of an impurity called N-nitrosodimethylamine (NDMA). NDMA, which is considered […]
SMi Group reports: Leaders in the lyophilization industry to share their expertise and knowledge atSMi’s 4th annual conference – Lyophilization USA, November 15 – 16, New Jersey. Recently, event organisers caught up with some of […]
GSK announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor modulating agent (TAMA) for the treatment of psoriasis and atopic dermatitis […]
SIGA Technologies has secured approval from the US Food and Drug Administration (FDA) for its TPOXX (tecovirimat) for the treatment of smallpox. TPOXX is claimed to be the first drug with an indication for treatment […]
Genmab has signed a collaboration and exclusive license agreement with Immatics Biotechnologies to work on next-generation bispecific cancer immunotherapies. The partnership will engage in the discovery and development of next-generation bispecific immunotherapies for multiple cancer […]